Personalized and Precision Medicine Journal

Abstract Urological issues in renal people with transplants include more than just posttransplant consequences. These issues contribute significantly to patient death and morbidity, resulting in long-term consequences for graft viability. Finally, transplantation is a key component of the urological network; hence, the transplant team ought to be ready for predictable and unforeseen urological difficulties in both the immediate and future. These mostly comprise surgical urological problems (urine leaks, ureteral stenosis, and vesicoureteral reflux) and bladder outlet blockage. A great deal has been achieved in the therapy of urological problems in the past few decades, owing mostly to developments in endourologic procedures. The purpose of this study is to outline the therapy of urological disorders following a renal transplant in light of present knowledge.

Abstract Cancer, the second foremost worldwide cause of mortality, affects individuals both physically and emotionally. Traditional therapies, including surgery, chemotherapy, and radiation, have detrimental consequences, necessitating the pursuit of more targeted methods. Precision medicine facilitates more tailored therapies. The introduction of next-generation sequencing technology, as well as the growing frequency of large-scale tumor molecular profiling programs throughout the world, have changed cancer diagnosis and treatment. With the increasing availability of comprehensive genetic tests in medical and scientific settings, healthcare practitioners face complex hurdles in understanding and translating data. The article encapsulates the existing and forthcoming strategies for the implementation of precision cancer therapy, emphasizing the obstacles and potential ways to enhance the understanding and optimize the therapeutic value of molecular profiling outcomes.